Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Realm of Illumination | 2026 | Seed | Undisclosed | — |
| TuringQ | 2026 | Series B | Undisclosed | Shanghai |
| Terminal brain technology | 2026 | Seed | Undisclosed | Shenzhen |
| BrainCo | 2026 | Series Unknown | $286.4M | Somerville |
| PRCXI Biotechnology | 2025 | Series A | Undisclosed | Suzhou |
| HemaCell | 2025 | Debt Financing | $17.1M | Suzhou |
| Greenon Biotech | 2025 | Series B | $14.2M | Wuhan |
| Lingtai Biotechnology | 2025 | Series B | $28.4M | Shanghai |
| HitGen | 2025 | Grant | Undisclosed | Chengdu |
| Volant Aerotech | 2025 | Series B | Undisclosed | Minhang |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 26 | Realm of Illumination | Seed | Undisclosed | — |
| 27 | TuringQ | Series B | Undisclosed | Shanghai, China |
| 28 | Terminal brain technology | Seed | Undisclosed | Shenzhen, China |
| 29 | BrainCo | Series Unknown | $286.4M | Somerville, United States |
| 30 | PRCXI Biotechnology | Series A | Undisclosed | Suzhou, China |
| 31 | HemaCell | Debt Financing | $17.1M | Suzhou, China |
| 32 | Greenon Biotech | Series B | $14.2M | Wuhan, China |
| 33 | Lingtai Biotechnology | Series B | $28.4M | Shanghai, China |
| 34 | HitGen | Grant | Undisclosed | Chengdu, China |
| 35 | Volant Aerotech | Series B | Undisclosed | Minhang, China |
Realm of Illumination is an AI smarter hardware company that specializes in R&D for AI smart terminal equipment.
TuringQ is committed to the research of quantum information and manufactures optical quantum chips and optical quantum computers.
Terminal Brain Technology is an AIGC distributed computing power network platform.
BrainCo develops brain-computer interface technologies for wellness and education applications.
PRCXI Biotechnology is a biotech company that focuses on analytical instruments, bioinformatics and automation solutions for life sciences.
HemaCell is a new cell therapy company to regenerate hematopoietic lineages in vitro, with unique stem cell reprogramming.
Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals.
Lingtai Biotechnology is a pharmaceutical and biotechnology based company that develops targeted protein degradation drugs.
HitGen is provides biological reagents and services to support drug discovery research.
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL.
Qingsi Intelligence focuses on the hybrid use of large and small AI models in the realm of vision.
Yixi Technology is a high-temperature superconducting magnet company.
Qianpeng Technology is a service provider specializing in biomimetic ceramic materials and intelligent manufacturing of biomimetic teeth.
AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.
Agibot creates humanoid robots for real-world tasks and multi-robot collaboration.
Innoscience is an 8-inch Integrated Device Manufacture (IDM) that focuses on GaN technology.
ZSPepLib is a polypeptide drug developer.
Zhongshu Ruizhi Technology applies cutting-edge technologies like big data and artificial intelligence (AI) to important industry scenarios.
Zhong An is an Internet-based insurance company that sells all its products online along with handling claims.
Tiejin Technology is a humanoid robotics company that provides research and development related to micro and ultra-micro bearings.
Rongrui Technology is a green biomanufacturing company that is involved in industrial enzyme research and development.
Mingxin Digital is a financial technology company dedicated to driving industrial credit management with digital technology.
LightSail Technology is a professional Internet marketing service provider, focusing on Internet marketing and brand operation.
Acchrom Tech is a technology company focusing on high-end liquid chromatography.
RootPath is a biotechnology company developing a powerful personalized T cell therapy platform that bridges precision medicine.
CDH Investments has invested in 137 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
CDH Investments's top investment sectors include Biotechnology, Manufacturing, Artificial Intelligence (AI), Semiconductor, Information Technology. The firm invests across 39 different industry categories.
Among tracked funding rounds, Zhong An received $499.4M in a Post Ipo Equity round. CDH Investments's total known invested capital is $6.2B.
CDH Investments's average investment size is $73.5M across its portfolio of 137 companies.
Recent CDH Investments portfolio additions include Realm of Illumination, TuringQ, Terminal brain technology, BrainCo, PRCXI Biotechnology. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors